Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 3Neoplasms 3Carcinoma, Hepatocellular 3Neoplasm Metastasis 2Glioma 2Glioblastoma 2Triple Negative Breast Neoplasms 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Nasopharyngeal Carcinoma 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Carcinosarcoma 1Camurati-Engelmann Syndrome 1Breast Neoplasms 1

Interventions

Cisplatin 123Gemcitabine 70Radiotherapy, Intensity-Modulated 56toripalimab 39Capecitabine 36Fluorouracil 33Docetaxel 32Radiotherapy 24camrelizumab 23Drug Therapy 20nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12apatinib 11Chemoradiotherapy 11tislelizumab 10sintilimab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Induction Chemotherapy 10Immune Checkpoint Inhibitors 10Specimen Handling 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nasopharyngeal Carcinoma × LY-2157299 × Clear all
NCT04605562 2021-09-05

Umbrella Biomarker-Guided Therapy in NPC

Sun Yat-sen University

Phase 2 Not yet recruiting
206 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡